Conversely, Ouchi et al. found elevated binding in the midbrain contralateral to the clinically affected side in PD (versus controls), correlating with putaminal DAT levels (using 11C-β-CFT-PET) and motor severity [189]. The gene discussed is SLC6A3; the disease is Parkinson disease.